Go to content
UR Home

HCC recurrence in HCV‐infected patients after liver transplantation: SiLVER Study reveals benefits of sirolimus in combination with CNIs – a post‐hoc analysis

URN to cite this document:
DOI to cite this document:
Werner, Jens M. ; Hornung, Matthias ; Krah, Rubertha ; Götz, Markus ; Schnitzbauer, Andreas A. ; Schlitt, Hans J. ; Geissler, Edward K. ; the International SiLVER study group, .
License: Creative Commons Attribution Non-commercial 4.0
PDF - Published Version
Date of publication of this fulltext: 26 Jan 2021 18:21

This publication is part of the DEAL contract with Wiley.


Factors affecting outcomes in liver transplant (LTx) recipients with hepatocellular carcinoma (HCC) and hepatitis C viral (HCV) infection include the choice of immunosuppression. Here, we analyzed the HCV+ subgroup of patients from the randomized controlled, international SiLVER Study. We performed a post hoc analysis of 166 HCV+ SiLVER Study patients regarding HCC outcome after LTx. Control ...


Owner only: item control page
  1. Homepage UR

University Library

Publication Server


Publishing: oa@ur.de
0941 943 -4239 or -69394

Dissertations: dissertationen@ur.de
0941 943 -3904

Research data: datahub@ur.de
0941 943 -5707

Contact persons